What is PYXS's dilution risk score?

PYXS currently has a DilutionScore of 56/100, indicating high dilution risk. DilutionWatch monitors PYXS SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for PYXS?

DilutionWatch tracks 25 SEC filing types for PYXS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PYXS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PYXS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PYXS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PYXS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PYXS Dilution Risk Score: 56/100 (HIGH)

📊 Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

85

📊 Float Risk

25

⚠️ Warrant Exposure

40

🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

33%

🔄 Reverse Split 45%

• 50-day avg $1.79 approaching $1 threshold

• Only 5 months cash — financial pressure

💰 Capital Raise 35%

• Low cash runway: 5 months remaining

🔔 Track PYXS — Get forecast alerts →

💹 Market Data

Market Cap$114.04M

Shares Outstanding63.36M

Float40.40M

Cash$41.02M

DebtN/A

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 12.4% shares (2026Q1 vs prior)

77 institutional holders · 31.46M shares

#1 Pfizer Inc 7.03M shares

#2 Laurion Capital Management LP 5.00M shares

#3 GordonMD Global Investments LP 4.12M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.29M

Days to Cover1.2

% of Float5.7%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021

4 INSIDER TRANSACTION Mar 25, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for PYXS Shareholders

Pyxis Oncology, Inc. (PYXS) has a DilutionScore of 56/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: PYXS has approximately 5 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for PYXS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PYXS alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

🔬 More Research for PYXS

📊 PYXS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PYXS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

PYXS — Pyxis Oncology, Inc. Dilution Risk Tracker